Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt Pathway to Improve Insulin Resistance Induced by a High-Fat Diet in Mice

References

• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–149. doi:10.1016/j.diabres.2013.11.002
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119:105–110. doi:10.1002/jcb.26174
   PubMed Web of Science ®Google Scholar
• Zhao H, Chen S, Gao K, et al. Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience. 2017;348:241–251. doi:10.1016/j.neuroscience.2017.02.027
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao G, Yang C, et al. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15:10567–10577. doi:10.3390/ijms150610567
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854. doi:10.1016/0092-8674(93)90529-Y
   PubMed Web of Science ®Google Scholar
• Thiel G, Rössler OG. Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol Res. 2017;117:166–176. doi:10.1016/j.phrs.2016.12.029
   PubMedGoogle Scholar
• Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012;32:537–541. doi:10.1016/j.nutres.2012.06.003
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCT method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Zou Q, Mao Y, Hu L, Wu Y, Ji Z. miRClassify: an advanced web server for miRNA family classification and annotation. Comput Biol Med. 2014;45:157–160. doi:10.1016/j.compbiomed.2013.12.007
   PubMedGoogle Scholar
• Gao D, Nong S, Huang X, et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38 MAPK pathways. J Biol Chem. 2010;285:29965–29973. doi:10.1074/jbc.M110.128694
   PubMed Web of Science ®Google Scholar
• Kim J, Bilder D, Neufeld TP. Mechanical stress regulates insulin sensitivity through integrin-dependent control of insulin receptor localization. Genes Dev. 2018;32:156–164. doi:10.1101/gad.305870.117
   PubMedGoogle Scholar
• Biasutto L, Mattarei A, Azzolini M, et al. Resveratrol derivatives as a pharmacological tool. Ann N Y Acad Sci. 2017;1403:27–37. doi:10.1111/nyas.13401
   PubMed Web of Science ®Google Scholar
• Weiskirchen S, Weiskirchen R. Resveratrol: how much wine do you have to drink to stay healthy? Adv Nutr. 2016;4:706–718. doi:10.3945/an.115.011627
   Google Scholar
• Abbasi Oshaghi E, Goodarzi MT, Higgins V, et al. Role of resveratrol in the management of insulin resistance and related conditions: mechanism of action. Crit Rev Clin Lab Sci. 2017;54:267–293. doi:10.1080/10408363.2017.1343274
   PubMed Web of Science ®Google Scholar
• Li J, Huang W, Tu R, Zhong G, Luo B, He Y. Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt. Acta Pharmacol Sin. 2017;38:182–191. doi:10.1038/aps.2016.109
   PubMed Web of Science ®Google Scholar
• Roggli E, Gattesco S, Caille D, et al. Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice. Diabetes. 2012;61:1742. doi:10.2337/db11-1086
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Beland FA. Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease. Expert Opin Drug Met. 2013;9:713–724. doi:10.1517/17425255.2013.783817
   PubMed Web of Science ®Google Scholar
• Liang J, Liu C, Qiao A, et al. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis. J Hepatol. 2013;58:535. doi:10.1016/j.jhep.2012.10.024
   PubMed Web of Science ®Google Scholar
• Jordan SD, Krüger M, Willmes DM, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011;13:434–446. doi:10.1038/ncb2211
   PubMed Web of Science ®Google Scholar
• Pan LY, Zhang XH, Yin XH. Advance of mechanisms of diabetic cardiomyopathy. Chin J Cardiovasc Med. 2017;122:143–146.
   Google Scholar
• Very N, Vercoutter-Edouart AS, Lefebvre T, et al. Cross-dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR axis in human chronic diseases. Front Endocrinol. 2018;9:602. doi:10.3389/fendo.2018.00602
   PubMedGoogle Scholar
• Sun XH, Wang Y, Mu YL. Alteration of PI3K/Akt/mTOR signaling during development of diabetic cardiomyopathy and regulation of sirt1. Chin Pharmacol Bull. 2017;33:793–798.
   Google Scholar
• Guo LP, Zhang ZJ, Li RT, et al. Influences of LncNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:253–261. doi:10.26355/eurrev_201901_16771
   PubMedGoogle Scholar
• Lin X, Shi H, Cui Y, et al. Dendrobium mixture regulates hepatic gluconeogenesis in diabetic rats via the phosphoinositide-3-kinase/protein kinase B signaling pathway. Exp Ther Med. 2018;16:204–212. doi:10.3892/etm.2018.6194
   PubMedGoogle Scholar
• Zhang H, Ge Z, Tang S, Meng R, Bi Y, Zhu D. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells. Mol Med Rep. 2017;16:2295–2301. doi:10.3892/mmr.2017.6810
   PubMedGoogle Scholar
• Chiara V, Giuliana M, Cinzia G, et al. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology. 2014;146:1060–1069. doi:10.1053/j.gastro.2013.12.016
   PubMedGoogle Scholar
• Zhao H, Shu L, Huang W, et al. Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4. Diabetes Metab Syndr Obes. 2019;12:401–411. doi:10.2147/DMSO.S198830
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen T, Huang H, et al. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma. Oncotarget. 2017;8:20133–20144. doi:10.18632/oncotarget.15448
   PubMedGoogle Scholar